Has Eva Rivera received payments from drug or device companies?

Yes. Drug and device makers reported $5,567 in general payments to Eva Rivera across 328 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Eva Rivera did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Eva Rivera come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Eva Rivera

Family · Modesto, CANPI 1700222627

Payments from drug & device makers

$5,567in general payments, 2019–2025

Across 328 payments — averaging $16.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
Takeda Pharmaceuticals U.S.A., Inc.$415
Ardelyx, Inc.$380
Ironwood Pharmaceuticals, Inc$267
Braintree Laboratories, Inc.$228
plus $2K from 19 others

What the payments were for

Food & beverage$5,48799%
Education$801%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	98	$1,407
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	90	$1,082
Takeda Pharmaceuticals U.S.A., Inc.	34	$415
Ardelyx, Inc.	16	$380
Ironwood Pharmaceuticals, Inc	10	$267
Braintree Laboratories, Inc.	10	$228
Redhill Biopharma Inc.	10	$196
Johnson & Johnson(2 entities)	7	$195
Lilly USA, LLC	6	$164
Madrigal Pharmaceuticals	5	$157
Celltrion USA Inc.	7	$151
Sanofi	6	$147
Intercept Pharmaceuticals, Inc.	6	$137
Ipsen Biopharmaceuticals, Inc	5	$114
Otsuka America Pharmaceutical, Inc.	1	$106
Merck	4	$78
Novo Nordisk	2	$64
Aimmune Therapeutics, Inc.	2	$53
Regeneron Healthcare Solutions, Inc.	1	$44
Phathom Pharmaceuticals, Inc.	2	$44
Organon	2	$39
QOL Medical, LLC	1	$33
Albireo Pharma, Inc.	1	$28
Boston Scientific	1	$25
Nestle Healthcare Nutrition Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LINZESS$113
REXULTI$106

How this compares

$5,567 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.

See all family providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
CreonLipase/Protease/Amylase	16	$34,535
LinzessLinaclotide	42	$32,401
Dexlansoprazole DrDexlansoprazole	11	$2,748
Pantoprazole Sodium	37	$631
Omeprazole	54	$569
Famotidine	27	$530
Lansoprazole	31	$499

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieCreon, Linzess	$1,407	$66,93658 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,634 family providers in California.

Other family in Modesto

Lori RobertsonChino Hills$475K
Annette ShonLos Angeles$406K
Nancy GardettoSan Diego$394K
Lisa HigginsHanford$311K
Jennifer TougasBakersfield$302K
Kim SchaferSacramento$288K
Dawn MeyerSan Diego$270K
Jennifer KangCerritos$255K
Jenine StoneEscondido$231K
Erin DwyerSan Diego$189K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →